Market Research Blog – Page 1600 – New Product Development

GCC Shisha Tobacco Industry to Reach USD 2,066.3 Million by 2034 at a CAGR of 6.4%

The shisha tobacco market in the Gulf Cooperation Council (GCC) is value, with sales expected to reach US$ 1.1 billion in 2024. This growth is partly driven by a concerning rise in shisha use among young people. Analysts predict the market will continue to expand at a healthy clip of 6.4% annually, reaching a value of US$2.1 billion by the end of the forecast period.

Shisha in the GCC: A Cloud of Controversy with a Silver Lining

The shisha tobacco market in the GCC is a puff of mixed signals. While its popularity simmers among young adults, fueled by social gatherings and flavored offerings, a storm of health concerns and educational campaigns are brewing.

Get your Sample Report Here! https://www.futuremarketinsights.com/reports/sample/rep-gb-15722

Perfect Storm for Popularity:

Youthful Cravings: Peer pressure and a lack of awareness about the health risks are driving shisha use among youngsters.
Easy Access: The widespread availability of shisha products makes them tempting for teenagers and young adults.
The Allure of the Hookah Cafe: The trendy hookah cafe culture, particularly among millennials, normalizes shisha use as a leisure activity. Light-flavored options further entice new users.
Luxury Shisha: Even high-end hotels cater to the demand, offering shisha as part of the Middle Eastern experience.
Social Smoke: The rising insistence on shisha at social gatherings strengthens its appeal.

Clouds of Concern:

Health Risks on the Horizon: Growing awareness of the dangers of shisha tobacco, including lung cancer and other health problems, is a cause for concern.
Disrupting the Smoke Ring: Anti-tobacco campaigns with strong marketing messages and educational programs are aiming to burst the bubble of shisha’s appeal.
Beyond Health: The Financial Burden: Educational efforts are shedding light not just on health issues, but also on the economic costs associated with tobacco use.

A Glimpse into the Future:

This analysis examines the business prospects for shisha vendors in the GCC and beyond. It also explores trends in the handheld marijuana vaporizer industry, a potentially related market.

Strong Shisha, Strong Sales?

The Potency Paradox: Strong shisha tobacco is predicted to dominate the GCC market, fueled by the misconception that it’s less harmful and the allure of diverse flavors.

Looking Beyond the Smoke:

Despite the current popularity of shisha, the growing awareness of its health risks and the effectiveness of educational campaigns suggest a potential decline in the future. The market analysis also explores alternative trends, offering a broader perspective for businesses in the region.

Key Takeaways from the Shisha Tobacco Market Study

In terms of sales channel, direct sales segment is expected to account for maximum sales in the GCC shisha tobacco market.
By product type, the strong shisha tobacco segment is expected to gain traction over the upcoming decade.
Based on flavor, the fruit flavors are expected to witness immense growth in the GCC shisha tobacco market
UAE shisha tobacco market is projected to witness robust growth in the GCC shisha tobacco market between 2022 and 2032

Who is winning?

Leading shisha tobacco manufacturer are focusing on aggressive promotional techniques, commercials, and new product launches to boost shisha tobacco sales growth in GCC. Major players present in the shisha tobacco market are-

Al-Eqbal Company for Investment PLC
Gulbahar Group
Samara Premium Tobacco Molasses
MSG Group of Companies
Romman Shisha Ltd
Middle East Tobacco Co. Ltd
Al Zawrae Industrial Company
Ugly Tobacco Hookah Inc.
Eastern Tombac & Tobacco Establishment
BMJ Industries
Debaj Tobacco Factory L.L.C
Royal Hookah UAE
AL MUFASA GEN.TRD. LLC

Gain Immediate Access to Detailed Market Insights! https://www.futuremarketinsights.com/checkout/15722

GCC Shisha Tobacco Market by Category

By Product Type:

Strong Shisha Tobacco
Mild Shisha Tobacco
Light Shisha Tobacco

By Flavor:

Fruit
Chocolate
Caramel
Mint
Blended
Others

By End User:

Beginner/ New Diver
Casual Diver
Active Diver
Advanced/ Professional Diver

By Sales Channel:

Direct Sales
Hypermarkets/ Supermarkets
Specialty Stores
Convenience Stores
Independent Small Stores
Online Retailers
Other Sales Channel

By Country:

KSA
United Arab Emirates(UAE)
Bahrain
Kuwait
Qatar
Oman

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of ~400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

GCC Medical Glove Industry Set to Reach USD 213.7 Million by 2034 at a 2.3% of CAGR

The GCC medical glove industry is poised for steady growth, with the market estimated to value around USD 170.3 million in 2024 and projected to achieve a moderate compound annual growth rate (CAGR) of 2.3% during the forecast period. According to recent industry analysis, the industry’s share is expected to reach nearly USD 213.7 million by 2034, driven by increasing emphasis on hygiene practices within the healthcare sector across the Gulf Cooperation Council (GCC) region.

Medical gloves play a crucial role in infection prevention and control measures, particularly in healthcare settings where maintaining stringent hygiene standards is paramount. The market’s growth is further fueled by rising healthcare expenditures, advancements in healthcare infrastructure, and expanding healthcare services across GCC countries.

As the healthcare sector continues to prioritize infection control and patient safety, the demand for high-quality medical gloves is expected to rise. This trend is reflective of broader efforts to improve healthcare standards and ensure the well-being of patients and medical professionals alike.

Get your PDF – Sample Report

This increase is mostly being caused by the GCC healthcare sector’s rising emphasis on maintaining high standards of cleanliness. Medical gloves are necessary to ensure the safety of patients and healthcare providers as well as to halt the spread of infections. Medical gloves are expected to be in demand in the future years due to rising awareness of hygiene standards, which will fuel the market’s growth

The GCC medical glove market is expected to benefit from several factors over the coming years, including:

Growing awareness of hygiene protocols within the healthcare sector
Increasing focus on patient safety
Rise in medical procedures requiring glove use

While the projected growth rate is moderate, the overall market size is expected to expand steadily, reflecting the ongoing importance of medical gloves in the GCC healthcare landscape.

Key Takeaways:

By raw material, the latex material segment is expected to hold 80.2% of the total market share in 2021, expanding at 7.9% CAGR during the forecast period.
Based on product type, the examination gloves segment is projected to command 55.6% of total sales in 2021, expanding at 8.1% CAGR.
By form, the powdered form segment is expected to hold 63.7% of the total market share in 2021, expanding at 8.0% CAGR.
By type of use, sales of disposable gloves are anticipated to hold 90.5% of the total market share 2021, and are to projected to increase at a robust 8.0% CAGR over the forecast period.
By end use, hospitals will account for 67.2% of total sales in 2021.
By distribution channel, the direct selling channel will account for 55.1% of the total market share in 2021.
Kingdom of Saudi Arabia (KSA) is anticipated to hold the largest share of 76.2% of the GCC medical gloves market in 2021.

Competitive Landscape for GCC Medical Glove Industry

The overall industry is currently moderately competitive as there are a few manufacturers operating at scale in different Gulf countries.

Companies operating in the medical gloves industry are aiming to strengthen their position through partnerships, collaborations, mergers & acquisitions, and agreements with established players, and other healthcare institutions. In addition to this, governments in GCC countries are increasing their investments in the expansion of the healthcare sector, which in turn is encouraging the emergence of new regional players.

Customization : Available

Recent Developments in the GCC Medical Glove Industry

In January 2021, Medline Industries announced a strategic partnership with the University of California, Davis / UC Davis. Students returning to the campus were provided custom PPE kits to be worn to avoid the spread of the COVID-19 virus. This way awareness and education among the peers were spread to reduce the strain on healthcare professionals.

Kimberly-Clark Corporation introduced the Kimtech Opal Nitrile Gloves in February 2022, with the purpose of guarding against microbiological and chemical splash dangers. These innovative gloves don’t include latex or vulcanizing chemicals, which reduces the possibility of skin responses related to Type I and Type IV allergies

Key Companies Profiled:

Paul Hartmann AG
Hotpack Packaging Industries LLC
Falcon (Falcon Pack)
Deeko Bahrain
Salalah Medical Supplies Mfg. Co. LLC
United Medical Industries
NAFA Enterprises Ltd.
Liberty Industries, Inc.
Ansell Healthcare
Mckesson Corporation
Cardinal Health, Inc.
Medline Indsutries, Inc.
Dynarex Corporation
Top Glove Corporation Berhad
Kimberly-Clark Corporation
Semperit AG Holding

Key Segments Covered by GCC Medical Glove Industry Survey Report:

By Raw Material:

Latex
Nitrile Rubber
Vinyl Rubber
Polyisoprene
Other Materials

By Product Type:

Examination
Surgical
Chemotherapy

By Form:

Powdered form Gloves
Powder-free form Gloves

By Type of Use:

Disposable Gloves
Re-usable Gloves

By End User:

Hospital Use
Clinic Use
Ambulatory Surgery Centre Use
Diagnostic Imaging Centre Use
Rehabilitation Centre Use

By Distribution Channel:

Direct Selling Channel
Medical Store Channel
E-Commerce Channel
Other (Retail Store or Hypermarket) Channel

By Countries:

Kingdom of Saudi Arabia (KSA)
United Arab Emirates (UAE)
Qatar
Bahrain
Oman
Kuwait

Secure Your Market Analysis Now – Purchase Now to Access

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Breast Pump Market is Expected to Grow at a CAGR of 3.90% to Reach USD 2,672.30 Million by 2033 | FMI

The Breast Pump Market is poised for significant growth, with a projected market value of USD 2.67 billion by 2033. This represents a commendable Compound Annual Growth Rate (CAGR) of 3.90%, according to industry estimates.

This anticipated growth is underpinned by a confluence of factors, including technological advancements, increasing awareness about maternal health, and a rising emphasis on convenience for breastfeeding mothers. The Global Breast Pump Industry’s evolution aligns with the evolving landscape of healthcare and family-oriented technologies.

Get a Sample Copy of this Report Now!

Since the last few years, the percentage of working women in workplaces across the globe has been declining (46.2% in 2019 as compared to 50.9% in 1990 as per “Catalyst”).

Emerging economies are witnessing impressive growth in healthcare spending. This can be attributed to improvements in healthcare technology and changing lifestyles, which is fuelling the demand for breast pumps among urban women. According to WHO, global healthcare spending rose by 2.4% in 2014 over 2013. Healthcare spending is growing at a rate of 5% in developing regions. A rise in healthcare expenditure is expected to boost the overall adoption of breast pumps among women, especially in the Asia Pacific.

Breast pump adoption is as high as 85% among breastfeeding women at 3 months post-birth. Furthermore, marketplace discussions indicate that the availability of breast pump accessory products will also encourage the adoption of electric breast pumps in developed markets. In this regard, infant product manufacturers are increasingly bundling other pump-related products, such as nursing bras and breast pumping bras, to sell complete packages of breast pumps, which is more profitable than isolated sales. Electrical breast pump packages find more adoption than manual breast pump products due to better volume of output. These innovative solutions are projected to fuel Global Breast Pump Industry revenues in the global electric breast pump market during the forecast period.

Breast Pump Market Key Players:

Koninklijke Philips N.V.,
Pigeon Corporation,
Newell Brands,
Medela Inc.,
Ameda Inc.,
Hygeia II Medical Group Inc.,
Bailey Medical,
Mayborn Group Ltd. and Linco Baby Merchandise Works Co., Ltd.

The Electric breast pump market is more technologically advanced with higher product pricing and low penetration. This category of breast pump comprises few global breast pump manufacturing companies. Potential new entrants in the Global Breast Pump Industry are trying to capture and improve their market position by using innovative marketing strategies, such as inorganic growth. Breast pump manufacturers are expanding their product portfolio using the latest technologies.

The availability of BPA-free breast pump products is fuelling breast pump adoption in developed as well as more affluent markets in developing regions. In the recent past, breast pump manufacturers have begun offering bisphenol A or BPA-free breast pump products to increase sales. BPA is a chemical used to make milk containers or feeding bottles rigid and more resistant and has been associated with adverse health effects, such as neural and fertility issues. Examples of some BPA-free breast pump products are the Philips Avent Manual Comfort Breast Pump from Koninklijke Philips N.V. and BPA-free breast pumps by Medela, Inc.

The rapid rise in promotional/supporting campaigns for Breast Pump products is fuelling revenue growth of the Global Breast Pump Industry. In November 2012, leading breast pump manufacturer Medela launched a campaign titled ‘Virtual Human Milk Collection Campaign’ to commemorate Prematurity Awareness Month, where the breast pump manufacturer encouraged and demonstrated the importance of breast milk for infants and babies. Medela has also donated US$ 30,000 worth of breastfeeding-related products to various neonatal intensive care units across the U.S.

Some of the leading breast pump manufacturing companies analyzed in the report include Koninklijke Philips N.V., Pigeon Corporation, Newell Brands, Medela Inc., Ameda Inc., Hygeia II Medical Group Inc., Bailey Medical, Mayborn Group Ltd. and Linco Baby Merchandise Works Co., Ltd.

Additional Questions Answered

Readers can find detailed information about the important positive and negative factors likely to affect the Breast Pump market during the forecast period. Additionally, this Global Breast Pump Industry report also contains valuable information that can provide Breast Pump manufacturers with answers to critical questions, such as

Which types of products account for the maximum demand in the Global Breast Pump Industry and why?
Why is the sales of Breast Pump services and products highest in North America?
Which regulations in various regional segments are influencing the strategies of players in the Breast Pump market?
Why is APEJ currently attracting traction in the Global Breast Pump Industry?
What are some of the current technology types and trends adopted by various Breast Pump companies?
What are the promotional strategies being applied by breast pump manufacturers to sustain themselves in the competitive Breast Pump market?

Click Here To Buy Your Detailed Report!

Breast Pump Market Key Segments Covered

by Product Type

Open System Breast Pumps
Closed System Breast Pumps

by Technology Type

electric
manual breast pumps

by End User

homecare settings
healthcare facilities

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

LED Tube Market: Registering Impressive Growth at a 10.4% CAGR by 2032

In 2022, the LED tube market is estimated to reach a valuation of US$ 6,712.1 Million, registering impressive growth at a CAGR of 10.4% from 2022 to 2032. The share of the LED tube market in the tube light market ranges from 21% to 26%. Additionally, sales in the LED tube market are projected to reach US$ 18,062.8 Million by 2032.

The demand is anticipated to witness a boost owing to the rising focus on smart city projects across the globe. The smart cities project focuses on energy efficiency and conservation of the environment resulting in a better future. This help in increasing awareness about the latest technologies and designs, which in turn is anticipated to create potential opportunities for the market participants operating in this market.

Hence, The majority of buyers these days usually spend more time perusing things on internet portals, which has elevated the market for LED tubes. These days, consumers weigh up several brands that provide superior features, comparability, cost, and accessibility. Online platforms continue to be able to quickly respond to the needs of customers.

Get Recently Updated Report of Market as Sample Copy! https://www.futuremarketinsights.com/reports/sample/rep-gb-15721

Several manufacturers are forming strategic agreements with Amazon, Flipkart, Alibaba, and other e-commerce platforms to expand their reach. Moreover, online commerce provides the freedom and convenience of picking the required goods from many choices. Furthermore, these websites provide a wide range of items and prices, allowing shoppers to take advantage of the best discounts and deals available.

Key Takeaways from the LED Tube Market Study

Residential users are anticipated to boost the growth of the LED tubes market house owners are ready to spend a high amount on better interiors of their homes due to a rise in their income.
Based on product type, LED T8 is expected to gain traction over the upcoming decade.
In the case of sales, sales from hypermarkets and supermarkets are anticipated to grow at an increasing pace during the forecast period.
Online retails are anticipated to rise at a rapid rate and will result in revolutionizing the LED tube market.

Who is winning?

Leading manufacturers of LED tube are focused on aggressive promotional strategies, advertisements, and new product launches that have driven sales growth of LED tube market globally.

Major players present in the LED tube market are

Acuity Brands, Inc.
IDEAL INDUSTRIES, INC.
Eaton Corporation
SAVANT TECHNOLOGIES LLC.
OSRAM Gmbh
Seoul Semiconductor
Zumtobel Group
Bajaj Electricals
Wipro Ltd
NEPTUN lights inc
Havells
Syska
Foshan Electrical and Lighting Co., Ltd
LED Tube Lighting Pty. Ltd.
Panasonic Corporation
Opple Lighting Co., Ltd.
Crompton Greaves Consumer Electricals Limited.
HPL Electric & Power Ltd
Toshiba Ltd
Other (on request)

Get More Valuable Insights

Future Market Insights, in its new offering, provides an unbiased analysis of the global LED tube market, presenting historical demand data (2017-2021) and forecast statistics for the period from 2022-2032.

The study divulges compelling insights on the LED tube market based on product type (LED T5, LED T8, LED T10, AND LED T12), end use (residential, commercial, industrial, architectural, hospital, education institutes, safety and security, and other end use application), sales channel (wholesaler/distributer, hypermarket/supermarket, specialty store, exclusive stores, department store, independent electronics stores, online retail stores, and other sales channel) across seven major regions.

Gain Immediate Access to Detailed Market Insights! https://www.futuremarketinsights.com/checkout/15721

Global LED Tube Market by Category

By Product Type:

LED T5
LED T8
LED T10
LED T12

By End Use:

Residential
Commercial
Industrial
Architectural
Hospital
Education Institutes
Safety & Security
Other End-Use Application

By Sales Channel:

Wholesalers/Distributors
Hypermarkets/Supermarkets
Specialist Stores
Exclusive Stores
Department Stores
Independent Electronic Stores
Online Retailers
Other Sales Channel

By Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa(MEA)

About Future Market Insights (FMI)

Contact Us:

Biopharmaceutical Contract Manufacturing Market is anticipated to expand at an 8.8% CAGR and reach USD 25.1 Billion by 2034 | FMI

The biopharmaceutical industry is experiencing a significant shift towards outsourcing manufacturing. The global Biopharmaceutical Contract Manufacturing Market is projected to surge at a staggering Compound Annual Growth Rate (CAGR) of 8.8%, according to a recent market analysis. This translates to a market value skyrocketing from USD 10.7 billion in 2024 to a remarkable USD 25.1 billion by 2034. This near doubling in size within a decade underscores the growing trend of biopharmaceutical companies relying on contract manufacturing organizations (CMOs).

The biopharmaceutical contract manufacturing sector offers a myriad of advantages, including access to cutting-edge technologies, expedited time-to-market for new pharmaceuticals, and enhanced flexibility. These compelling benefits have prompted several multinational corporations to leverage the expertise of contract manufacturing firms.

Request a Sample of this Report Now!

Regional Insights:

The U.S. dominates the North American region with a total market share of 91.0% in 2021 and is projected to continue experiencing high growth throughout the forecast period.

Germany is set to exhibit a CAGR of over 11.5% in the European Biopharmaceutical Contract Manufacturing Industry during the forecast period. In this region, the next-generation therapy market is believed to be driven by biological treatment options compared to the pharmaceutical option.

China holds a 34.8% share in the East Asia market in 2021 and is projected to increase at a CAGR rate of 13.5% during the forecast period. The growth of the Biopharmaceutical Contract Manufacturing Industry in the country is growing because most of the pharma and biopharma companies are focusing on capitalizing on the growth.

Asia Pacific is gaining attention among manufacturers for biologics production at reduced manufacturing costs. Emerging regions offering greater profit margins are major focus points for biopharmaceutical contract manufacturing, globally.”

Key Takeaways of Biopharmaceutical Contract Manufacturing Market Study

Although microbial-based platforms are abundantly used for the production of pharmaceuticals, mammalian-based cell culture is expected to gain traction during the forecast period, owing to higher efficiency and increasing demand.
In terms of product type, monoclonal antibodies currently hold a larger share of the biopharmaceutical contract manufacturing market, due to their superior efficacy as well as increasing adoption for the treatment of chronic diseases.
North America is anticipated to be the most lucrative region in the global Biopharmaceutical Contract Manufacturing Industry, offering growth opportunities to market players.
The commercial application of biopharmaceutical contract manufacturing is expected to contribute a higher share as compared to clinical application by the end of 2029.

Biopharmaceutical Contract Manufacturing Market Key Players:

Catalent Inc.
Lonza Group Ag
Patheon N.V. (Thermo Fisher Scientific Inc.)
Abzena Plc.
Sandoz International GmbH (Novartis AG)
Fujifilm Diosynth Biotechnologies (FUJIFILM Holdings)
Baxter Pharmaceutical Solutions LLC (Baxter Inc.)
AbbVie Contract Manufacturing (AbbVie Inc.)
Samsung Biologics Co. Ltd.
ProBioGen AG
Pfizer Centre Source Ltd (Pfizer Inc.)
Novasep
Biomeva GmbH
Kbi Biopharma Inc
Rentschler Biotechnologie GmbH
Ajinomoto Althea Inc. (Ajinomoto Co., Inc.)

Get Your Customized Impactful Report Now!

Segments Covered in Biopharmaceutical Contract Manufacturing Market Research:

By Platform Type:

Mammalian Based
Microbial Based

By Product Type:

Monoclonal Antibodies
Recombinant Protein
Vaccine
Insulin
Growth factor
Interferons
Others

By Application Type:

Clinical
Commercial

By Therapeutic Area Type:

Autoimmune Diseases
Oncology
Metabolic Diseases
Ophthalmology
Cardiovascular Diseases
Infectious Diseases
Neurology
Respiratory Disorders
Others

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Cosmetic Surgery Products Market Set to Reach USD 41.64 Billion by 2033 at a 8.1% of CAGR

The global cosmetic surgery products market is poised for substantial growth, with projections indicating a value of USD 19.09 billion in 2023 and expected to grow at a robust compound annual growth rate (CAGR) of 8.1% to reach USD 41.64 billion by 2033. This expansion is driven by increasing awareness and acceptance of cosmetic procedures among the younger demographic, coupled with advancements in technology facilitating various surgical and non-invasive treatments.

Cosmetic surgery products encompass a wide range of equipment and technologies used in aesthetic procedures, addressing concerns from body contouring to facial rejuvenation. The market’s growth is buoyed by the availability of advanced surgical tools and non-invasive technologies, such as fat-freezing systems, which are increasingly preferred for their efficacy and minimal recovery times.

The market’s trajectory reflects a dynamic blend of innovative procedures, minimally invasive techniques, and a broader acceptance of cosmetic enhancements across various demographics. This surge is further bolstered by a continuous stream of research and development, leading to safer, more effective products that cater to diverse consumer needs.

Request a Sample Copy of This – Report Now

The emergence of advanced technical equipment, such as non-invasive body contouring systems that utilize fat-freezing technology, is anticipated to present favorable growth prospects for the industry in the upcoming ten years. According to the Aesthetic Society of the United States, 140,314 non-invasive body fat reduction treatments were carried out in 2020, placing it in the top 5 non-invasive procedures in the nation.

A Younger Generation Embraces Cosmetic Enhancement

The global cosmetic surgery products market is experiencing significant growth, fueled by a growing trend among younger demographics. Increased awareness of cosmetic procedures and a desire for a more youthful appearance are driving demand for these products.

Technological Advancements Fuel Market Innovation

The market is not only expanding in terms of user base, but also evolving rapidly due to advancements in technology. The development of innovative products like non-invasive body contouring systems utilizing fat-freezing technology is creating exciting possibilities for minimally invasive cosmetic procedures. This trend is expected to continue, offering a wider range of safe and effective cosmetic options for patients.

Key Takeaways:

The global cosmetic surgery products market is estimated to reach US$41.64 billion by 2033, reflecting a significant rise from US$19.09 billion in 2023.
This growth is projected at a steady compound annual growth rate (CAGR) of 8.1% throughout the forecast period.
Rising young consumer interest in cosmetic procedures and advancements in surgical technology are key drivers for market expansion.

Customization – Available

Competition Analysis:

Key players in the global cosmetic surgery products include Mentor Corporation, Allergan, Candela Corp, Lumenis Ltd., Cutera Inc, Palomar Medical, Iridex Corp, DermaMed Pharmaceutical Inc, Solta Medical, Medtronic plc, Syneron Medical Ltd., Johnson & Johnson Services, Inc. Cynosure Inc., and several others.

Key Updates from the Industry

Apyx® Medical Corporation introduced the Apyx One Console, its latest-generation Renuvion generator, to the United States in January 2023. This state-of-the-art console boasts a multi-functional design, integrating an advanced 3-in-1 energy system that empowers plastic and cosmetic surgeons to utilize Renuvion technology alongside full monopolar and bipolar energy options.
ZimVie made an announcement in November 2022 about the launch of their TSX implant in the United States. This implant represents the latest advancement in their range of surgical, restorative, and digital dentistry solutions. The TSX implants are specifically designed for immediate extraction and loading procedures, offering enhanced predictability and stability when placed in both soft and dense bone.
Health Canada granted regulatory approval to Sientra’s breast implants in March 2022. The company plans to offer these breast implants in Canada by collaborating with its local partner, Kai Aesthetic. Under the distribution agreement, Sientra is committed to maintaining the utmost product quality, safety, and service standards, ensuring the well-being of patients and plastic surgeons alike.
In March 2021, Iridex Corporation a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced today that it has entered into a strategic collaboration with Topcon Corporation. Topcon is a Japanese-based manufacturer and distributor with approximately US$ 1.3 Billion in annual revenues, including US$ 430 Million from its eye care business.
In May 2020, AbbVie, announced that it has completed its acquisition of Allergan plc following receipt of regulatory approval from all government authorities required by the transaction agreement and approval by the Irish High Court.

Key Segments Profiled in the Global Cosmetic Surgery Products Market

By Product Type:

Cosmetic Surgery Implants
Breast Implants
Chin & Cheek Implants
Injectables
Botulinum Toxin
Soft Tissue Fillers
Dermal Fillers
Absorbable Fillers
Non-Absorbable Fillers
Cosmetic Surgery Lasers
Ablative Laser
Non-Ablative Laser
Microdermabrators
Liposuction Equipment
Cosmetic Surgery Services

By Application:

Face
Upper Body
Breasts
Hands
Stomach
Lower Body

By End User:

Hospitals
Ambulatory Surgical Centers
Clinics
Universities and Research Centers
Homecare Settings

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East & Africa

Act Now for Thorough Market Analysis – Purchase Now to Access

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Decubitus Ulcer Treatment Products Market to Expand, Valued at USD 8,503.4 Million by 2033 at a 5.5% of CAGR

The global market for decubitus ulcer treatment products market is poised for substantial growth, with anticipated demand reaching USD 4,989.4 million in 2023 and projected to grow at a compound annual growth rate (CAGR) of 5.5% to USD 8,503.4 million by 2033. This growth is driven by the increasing prevalence of decubitus ulcers among the geriatric population and individuals living with disabilities.

Decubitus ulcers, commonly known as bed sores or pressure sores, are open wounds that develop on the skin over bony areas of the body. They result from prolonged pressure, friction, or moisture on the skin, often exacerbated by immobility and poor blood circulation. The rising incidence of these ulcers underscores the critical need for effective treatment and prevention strategies.

The rising prevalence of these conditions among the elderly and disabled population highlights the urgent need for effective treatment products. As awareness grows, healthcare providers and caregivers are increasingly turning to innovative solutions to prevent and treat decubitus ulcers, thereby improving the quality of life for affected individuals.

Get your PDF – Sample Report

Combating Pressure Injuries: Decubitus Ulcer Treatment Offers Relief and Improved Care

The global decubitus ulcer treatment product market is experiencing steady growth, driven by the rising need for effective solutions to manage pressure injuries. Decubitus ulcers, also known as bed sores or pressure sores, are open wounds caused by prolonged pressure on the skin. These can develop in individuals with limited mobility or those who spend extended periods lying down.

Understanding Decubitus Ulcers and Treatment Options

Decubitus ulcers can be caused by various factors, including:

Constant Pressure: Unrelieved pressure on bony areas like the heels, tailbone, and hips can restrict blood flow and damage skin tissue.
Friction: Friction between the skin and bedsheets or other surfaces can contribute to ulcer formation.
Moisture: Excessive sweat, urine, or fecal incontinence can create a moist environment that weakens the skin.

The decubitus ulcer treatment market offers a variety of products to help prevent and manage these wounds, including:

Support Surfaces: Specialty mattresses and cushions designed to redistribute pressure.
Dressings: Advanced wound dressings to promote healing and manage moisture.
Skin Care Products: Lotions and cleansers to protect the skin from breakdown.

Key Takeaways:

The global decubitus ulcer treatment products market is expected to reach US$8,503.4 million by 2033, reflecting a rise from US$4,989.4 million in 2023.
This growth is projected at a consistent compound annual growth rate (CAGR) of 5.5% throughout the forecast period.
The aging population and increasing focus on pressure injury prevention are key drivers for market expansion.

Customization Available – Here

Market Competition:

Some of the key participants present in the global Decubitus Ulcer Treatment Products market include Mölnlycke Health Care AB, ConvaTec Group Plc., B. Braun Melsungen AG, Coloplast Corp., Smith & Nephew, 3M, Integra LifeSciences Corporation, Cardinal Health, and Tissue Regenix, among others.

Due to the presence of such a high number of participants, the market is highly competitive. While global players such as Mölnlycke Health Care AB, ConvaTec Group Plc., B. Braun Melsungen AG, Coloplast Corp., and Smith & Nephew account for a considerable market size, several regional-level players are also operating across key growth regions, particularly in North America.

Recent Developments

In June 2020, MBET Health announced the launch of a proactive solution, the Miracle Dressing Wound Care System (MDS), specially developed for the strong surge of pressure injuries, such as pressure ulcers, due to the enforced confinements caused by the COVID-19 lockdowns. The product is the first and only 21-day stay-in-place dressing and prevents pressure sores.
In April 2020, AxioBiosolutions announced the launch of MaxioCel, a next-generation wound care dressing made of chitosan to treat pressure ulcers. The product imparts 360-degree care with pain management, hemostatic, pain, and scar improvement properties.
In March 2020, Smith & Nephew announced the United States. Launch of their new offering of the PICO 14 Single Use Negative Pressure Wound Therapy System (sNPWT), which has a pump duration of up to 14 days. The new pump enhances the features and benefits of the previous generations of PICO sNPWT products and comes with an enhanced pump that requires less user intervention.

Key Companies Profiled:

Hill-Rom Company Inc.
Graham Field Health Products Inc.
Invacare Corporation
Sunrise Medical Inc.
ROHO Inc.
Kinetic Concepts Inc.
Span-America Medical Systems Inc.
Spenco Medical Corp
Cardinal Health
Smith & Nephew

Key Segments Profiled in the Decubitus Ulcer Treatment Products Industry Survey:

By Depth of Soft Tissue Damage:

Stage I
Stage II
Stage III
Stage IV

By Distribution Channel:

Hospitals Clinics
Public Hospitals
Private Clinics
Retail Pharmacies and Drug Stores
E-commerce

By Region:

North America
Europe
Latin America
Asia Pacific
Middle East & Africa

Unlock Comprehensive Market Analysis – Purchase Now to Access

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Dry Eye Syndrome Treatment Market is expected to reach USD 9,521 Million by 2033, with a CAGR of 6.4% | FMI

Millions of people struggle with dry eye syndrome, but relief is on the horizon. The global Dry Eye Syndrome Treatment Market is poised for significant growth, with a projected Compound Annual Growth Rate (CAGR) of 6.4% over the next decade. In 2023, the market already holds a substantial value of USD 5,120 million, and it’s expected to climb to an impressive USD 9,521 million by 2033.

Dry Eye Syndrome, a common ocular condition that affects millions worldwide, has prompted substantial advancements in treatment options. With this remarkable growth projection, the global Dry Eye Syndrome Treatment Industry is set to become a focal point of the healthcare industry in the coming years.

Get a Sample Report Now!

One such example is the Narayana Nethralaya, a super specialty eye hospital based out of India, a dedicated lab to diagnose and treat dry eyes. This lab aims to provide patients with awareness about eye lid problems such as Meibomian gland dysfunction, which lead to the development of dry eye syndrome.

Also, similar trend is observed in developed market such as U.S. Various government awareness campaigns and not for profit initiatives try to create awareness about the dry eye disease to the population that does not have access to eye care facilities. Eye Care America is an example of a public service organization run by the American Academy of Ophthalmology Foundation that provides free eye care through volunteer ophthalmologists.

Further, those who are age 65 or older and who have not seen an ophthalmologist in three or more years may be eligible to receive a comprehensive, medical eye exam and up to one year of care at no out-of-pocket cost. This consequently will increase the utilization of dry eye treatment products and drive the growth of the Dry Eye Syndrome Treatment Industry during the forecast period. .

Key Takeaways from Dry Eye Syndrome Treatment Market Study

Greater acceptance of artificial tears owing to improved patient comfort leads the artificial tears segment to account for the maximum share of 60.8% in 2021, expanding at 7.1% CAGR during the forecast period.
By prescription, Rx prescriptions are projected to account for 71.3% of the market share in 2022 indicating highest demand, since majority of population visit hospitals to get the checkup done, in turn increasing the numbers of Rx prescriptions.
Retail pharmacies, as distribution channel held the largest share of 60.8% in 2021 and is expected to grow with the same trend throughout the forecast period.
By region, North America held the largest share of 37.6% of the Dry Eye Syndrome Treatment Industry in 2021 indicating the growth due to high prevalence and high treatment adoption rate in North America.

“Growing incidence of dry eye syndrome due to growing aging population, and long working hours (increase in screen time) to drive the demand of Dry Eye Syndrome treatment products over the Decade,” says the FMI Analyst

Who is winning?

Dry Eye Syndrome Treatment Market Key Players :

Allergen plc. (Abbvie)
Novartis AG
Otsuka Pharmaceuticals Co.Ltd.
Bausch Health Companies Inc.
Akron Inc.
Johnson & Johnson Inc.
Thea Pharmaceuticals Limited
OASIS Medical
Altaire Pharmaceuticals Inc.
Boiron USA
Similasan Corporation
Scope Ophthalmics Ltd.
Reckitt Benckiser Group PLC
Medicom Healthcare Ltd
FDC Limited.
Lupin Limited
Jamjoom Pharmaceuticals Co.
Sentiss Pharma Private limited.

Some of the leading manufacturers of the dry-eye-syndrome treatment market focuses on the product launch and approvals with global expansion objectives, thereby, enhancing their market presence.

In January 2021, SIFI an Italy based international ophthalmic company launched SYNFO for moisturizing and lubrication in dry eye treatment.
In December 2020, Alcon Canada announced the launch of its new product Systane an ultra-hydration lubricant eye drops preservative free containing Hyaluronic acid and HP-guar
In November 2020, Santen Pharmaceutical launched Cationorm categorized as artificial tear for moisturisation and long lasting relief to dry eye.

Get Your Customized Impactful Report Now!

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global Dry Eye Syndrome Treatment Industry is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The study provides compelling insights on Dry Eye Syndrome Treatment Industry segment based on Product (Cyclosporine, Topical Corticosteroids, and Artificial Tears Punctal Plugs (removable, dissolvable), oral omega supplements, and others), prescription (Rx, OTC, Medical Device), distribution channel (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, and Online Pharmacies) across seven major regions.

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Protein Purification and Isolation Market to Reach USD 24.76 Billion by 2033 at a 10.6% of CAGR

The global protein purification and isolation market is poised for substantial growth, projected to achieve a significant market valuation of USD 9.03 billion by 2023 and expected to surpass USD 24.76 billion by 2033. With a moderate compound annual growth rate (CAGR) of 10.6% from 2023 to 2033, this market expansion is driven by increased funding in protein research, rising interest in structure-based drug design, and technological advancements in purification techniques.

Protein purification and isolation technologies are critical in biopharmaceutical research and drug development, enabling scientists to study and produce high-quality proteins for therapeutic applications. The market’s growth is further bolstered by governmental and private sector investments, supportive regulatory frameworks, and incentives aimed at fostering innovation in the pharmaceutical and biotechnology sectors.

Governments worldwide are bolstering the pharmaceutical and biotechnology industries by ramping up investments in research and development and launching initiatives aimed at promoting the growth of the protein purification and isolation sector. These efforts are further supported by incentives like tax breaks, grants, and investor-friendly regulations.

Request a Sample Copy of This – Report Now

Despite several challenges, the protein separation and purification sector is expanding. Because protein architectures vary so much, it can be difficult to achieve high purity and yield throughout the purification process. Certain proteins are difficult to purify by nature due to their stability, solubility, or molecular interactions. The expensive development and application of complex purification procedures and equipment is another barrier. It can be costly to investigate, develop, and scale up purification technologies, particularly for small biotech businesses or university research groups. The protein purification and separation industry’s long-term performance hinges on finding creative technologies, optimizing processes, and coming up with cost-effective solutions to these issues.

Key Takeaways from the Protein Purification and Isolation Market:

With a commanding market share of 31.9% in 2023, the United States solidifies its position as a leading protein purification and isolation industry player.
Germany holds a share of 6.8% in 2023, reflecting its presence and contribution to the protein purification and isolation industry.
Japan captures a share of 7.2% in 2023, indicating a strong market presence and growing demand for protein purification and isolation solutions in the country.
Australia exhibits a promising growth potential with a compound annual growth rate (CAGR) of 9.3% during the forecast period, showcasing increasing adoption of protein purification and isolation technologies in the country.
With an impressive CAGR of 16.5% during the forecast period, China signifies a booming protein purification and isolation market, reflecting high demand and significant growth opportunities in the region.
India presents a thriving protein purification and isolation market, projected to achieve a CAGR of 15.1% during the forecast period, highlighting a rapid adoption of these technologies in the country.
Protein interaction studies capture a substantial market share of 32.70% in 2023, indicating its significance and widespread adoption in various research and biotechnological applications.
Academic and research institutes dominate the market with a commanding 50.20% market share in 2023, reflecting their strong involvement and demand for protein purification and isolation techniques for various scientific studies and advancements.

Competitive Landscape for the Protein Purification and Isolation Market:

Protein purification and isolation market participants are attempting to increase their foothold by implementing tactics like new product launches, geographic expansion, mergers, acquisitions, and partnerships. For instance, in September 2021, GE Healthcare Life Sciences agreed to purchase BK Medical from Altaris Capital Partners, LLC, for USD 1.45 billion in cash. The deal was announced in December 2021.

In March of 2022, Thermo Fisher Scientific and Symphogen announced they would continue working together to supply biopharmaceutical R&D laboratories with platform workflows for quality monitoring and simplified characterization of complex therapeutic proteins. Thermo Fisher Scientific’s dominance in the protein purification and separation market is expected to be preserved thanks to this.

Customization Available – Here

Global Protein Purification and Isolation Market Key Players:

Merck KGaA
Thermo Fischer Scientific, Inc.
GE Healthcare Life Sciences
Qiagen NV.
Sigma-Aldrich Corporation
Agilent Technologies
Bio-Rad Laboratories, Inc.
Promega Corporation

Protein Purification and Isolation Market by Segmentation:

By Product:

Instruments
Consumables
Kits
Reagents
Columns
Magnetic Beads
Resins
Others

By Technology:

Ultrafiltration
Precipitation
Chromatography
Ion Exchange Chromatography
Affinity Chromatography
Reversed-Phase Chromatography
Size Exclusion Chromatography
Hydrophobic Interaction Chromatography
Electrophoresis
Gel Electrophoresis
Isoelectric Focusing
Capillary Electrophoresis
Western Blotting
Others

By Application:

Drug Screening
Biomarker Discovery
Protein-protein Interaction Studies
Diagnostics

By End Use:

Academic and Research Institutes
Hospitals
Pharmaceutical and Biotechnological Companies
CROs

By Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa

Unlock In-Depth Market Insights – Purchase Now to Access

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

North America and Europe Phototherapy Treatment Market is Anticipated to Reach USD 3.23 Billion by 2033, with a Compound Annual Growth Rate of 5.20% | FMI

The North America and Europe Phototherapy Treatment Market is shining bright with projected growth. According to market estimations, the market value is expected to reach a staggering USD 3.23 Billion by 2033. This translates to a remarkable Compound Annual Growth Rate (CAGR) of 5.20% throughout the forecast period, highlighting the increasing adoption of phototherapy treatments.

Currently valued at USD 1.95 Billion in 2023, the phototherapy treatment market is experiencing a transformative evolution. This burgeoning industry offers promising treatment options for a wide range of medical conditions.

Get a Sample of this Report Now!

The early beginning of acne in youngsters is associated with distorted eating patterns as well as excessive consumption of fried and ready-to-eat food products. Women also experience the emergence of severe acne and psoriasis as adults. The most lucrative market for phototherapy is North America, followed by Western Europe and Eastern Europe, according to a report titled “Phototherapy Treatment Market for Acne and Psoriasis North America and Europe Industry Analysis 2023 – 2033 and Opportunity Assessment; 2017 – 2027.” According to projections, the North American market would increase from US$ 594.5 Mn in 2016 to US$ 1,150.0 Mn by the end of 2027. Additionally, the U.S. currently controls more than three-fourths of the market for phototherapy treatments in North America.

The increasing adoption of phototherapy in dermatology clinics and hospitals in Europe is favouring the growth of the market in the region. Moreover, psychological burdens associated with acne and psoriasis are high in the region, compelling patients to seek professional help in the form of prescription treatments, phototherapy, and others. Germany and the UK are two of the major markets for phototherapy in Europe and are expected to remain dominant throughout the forecast period.

Key Excerpts from the Report Include:

Based on end users, hospitals currently account for the largest value share of the phototherapy treatment market for acne and psoriasis in North America and Europe. However, the preference for home care settings among patients is likely to grow shortly.
Demand for blue light therapy is relatively higher than other phototherapy types in both North America and Europe. This trend is expected to continue throughout the assessment period. The blue light phototherapy segment is estimated to reach a market valuation of US$ 1,067.1 Mn towards the end of 2027.

Phototherapy being a high-margin reconstructive technology is perceived as an opportunity for market players to invest in future growth.

Lifespan,
UC Irvine Health,
Buffalo Medical Group,
Blackrock Clinic Limited,
The Private Phototherapy Clinic Ltd.,
National Skin Centre,
and Massachusetts General Hospital

North America and Europe Phototherapy Treatment for Acne and Psoriasis Market – Taxonomy

By Disease Type

Psoriasis
- Guttate Psoriasis
- Inverse Psoriasis
- Pustular Psoriasis
- Erythrodermic Psoriasis
- Plaque Psoriasis
Acne
- Acne Vulgaris
- Acne Conglobata
- Acne Fulminans
- Gram-Negative Folliculitis
- Acne Rosacea
- Pyoderma Faciale

By Phototherapy Type

Blue Light Phototherapy
Red Light Phototherapy
Intense Pulsed Light (IPL) Phototherapy
Narrowband UVB Phototherapy
Psoralens+Ultravioletlight A (PUVA) Phototherapy

By End User

Hospitals
Dermatology Clinics/Skin Care Centres
Wellness Centres
Home Care Settings

Get Ahead with Comprehensive Information – Purchase Now!

Author

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube